Healthcare & Life Sciences
Jocasta Neuroscience
United States
series-a
series-a
Stage
1
Investors
About
Jocasta Neuroscience, Inc. is a biotechnology company developing α‑klotho protein-based therapies to treat cognitive decline associated with various forms of dementia. The company is focused on translating α‑klotho biology into therapeutic approaches for neurodegeneration.
Explore Jocasta Neuroscience's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.